Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt
November 25, 2024 07:30 ET
|
Evome Medical Technologies Inc.
SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 – Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) today reported financial results for the third...
Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders
November 08, 2024 10:55 ET
|
Evome Medical Technologies Inc.
SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today announced the results from its annual general and special meeting of...
Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan
August 15, 2024 07:30 ET
|
Evome Medical Technologies Inc.
Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome...
Evome Medical Technologies Reports Second Quarter 2024 Financial Results
August 12, 2024 07:30 ET
|
Evome Medical Technologies Inc.
Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug. ...
Evome Medical Technologies Retains irlabs for Investor Relations Services
July 03, 2024 07:30 ET
|
Evome Medical Technologies Inc.
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR Labs...
Evome Medical Technologies Announces Securities Issuances
June 14, 2024 17:00 ET
|
Evome Medical Technologies Inc.
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange (the...
Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2
June 03, 2024 07:30 ET
|
Evome Medical Technologies Inc.
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from April...
Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt
May 30, 2024 07:30 ET
|
Evome Medical Technologies Inc.
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue...
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled
April 12, 2024 07:30 ET
|
Evome Medical Technologies Inc.
NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the “Company” or “Evome”) highlighted the strengthening credit relationship with Pathward, N.A. (“Pathward”), the...
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt
April 02, 2024 11:18 ET
|
Evome Medical Technologies Inc.
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) has reached an agreement with EB Sports Corp. (the “Buyer”), the parent company...